John Valliant's Net Worth
$5.36 Million
Who is John Valliant?
John Valliant has an estimated net worth of $5.36 Million. This is based on reported shares in Fusion Pharmaceuticals Inc..
SEC CIK
John Valliant's CIK is 0001813574
Past Insider Trading and Trends
2020 was John Valliant's most active year for acquiring shares with 3 total transactions. John Valliant's most active month to acquire stocks was the month of January. 2022 was John Valliant's most active year for disposing of shares, totalling 45 transactions. John Valliant's most active month to dispose stocks was the month of February. 2023 saw John Valliant paying a total of $0.00 for 500,000 shares, this is the most they've acquired in one year. In 2022 John Valliant cashed out on 213,787 shares for a total of $1,599,719.14, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Fusion Pharmaceuticals Inc. (FUSN) Snapshot price: $11.81
Chief Executive OfficerJohn Valliant owns 318,147 units of Common Stock which is worth $3,757,316.07. From 2020 to 2023 John Valliant disposed a total of 213,787 shares of Fusion Pharmaceuticals Inc. equalling to $1,599,719.14.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| -2.66% | -8.69K |
$6.04 | -$52,510.70 | 318.15K |
Scheduled
|
Apr 25 - Apr 27
| ||
Form 4
| -0.39% | -1.29K |
$6.01 | -$7,750.56 | 326.84K |
Scheduled
|
Apr 20 - Apr 21
| ||
Form 4
| -9.10% | -32.85K |
$6.87 | -$225,654.04 | 328.13K |
Scheduled
|
Apr 11 - Apr 13
| ||
Form 4
| -0.60% | -2.18K |
$7.55 | -$16,457.32 | 360.98K |
Scheduled
|
Apr 6 - Apr 8
| ||
Form 4
| -1.04% | -3.80K |
$7.72 | -$29,324.00 | 363.16K |
Scheduled
|
Apr 1 - Apr 5
| ||
Form 4
| -0.08% | -300.00 |
$7.52 | -$2,256.00 | 366.96K |
Scheduled
|
Mar 30
| ||
Form 4
| -2.73% | -10.30K |
$7.54 | -$77,694.00 | 367.26K |
Scheduled
|
Mar 25 - Mar 29
| ||
Form 4
| -1.26% | -4.80K |
$7.52 | -$36,092.00 | 377.56K |
Scheduled
|
Mar 21 - Mar 23
| ||
Form 4
| -0.93% | -3.60K |
$7.53 | -$27,126.44 | 382.36K |
Scheduled
|
Mar 17 - Mar 21
| ||
Form 4
| -0.39% | -1.50K |
$6.97 | -$10,459.00 | 385.96K |
Scheduled
|
Mar 14 - Mar 16
| ||
Form 4
| -0.72% | -2.82K |
$7.03 | -$19,831.68 | 387.46K |
Scheduled
|
Mar 9 - Mar 11
| ||
Form 4
| -3.58% | -14.50K |
$7.17 | -$103,944.68 | 390.29K |
Scheduled
|
Mar 4 - Mar 8
| ||
Form 4
| -6.38% | -27.59K |
$7.44 | -$205,200.63 | 404.79K |
Scheduled
|
Mar 1 - Mar 3
| ||
Form 4
| -3.08% | -13.75K |
$7.50 | -$103,175.64 | 432.38K |
Scheduled
|
Feb 24 - Feb 28
| ||
Form 4
| -7.91% | -38.30K |
$7.79 | -$298,434.47 | 446.13K |
Scheduled
|
Feb 18 - Feb 23
| ||
Form 4
| -8.93% | -47.50K |
$8.08 | -$383,807.98 | 484.43K |
Scheduled
|
Feb 15 - Feb 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6 - Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||